Alprazolam in the Treatment of Panic Disorders
The DOI matches its Crossref record.
Abstract
An open clinical trial of alprazolam therapy of patients with panic disorder or agoraphobia with panic attacks was undertaken to clarify certain issues not resolved by previous studies. These included the proportion of patients who significantly improve with alprazolam; the relative time courses for improvement in panic attacks, anticipatory anxiety, and phobic avoidance; whether successful alprazolam treatment alters vulnerability to panic with sodium lactate infusion; and what factors predict response to alprazolam in panic patients. Thirty patients meeting DSM-III criteria for panic disorder or agoraphobia with panic attacks completed a 12-week open clinical trial, and 22 were considered responders. In responders, panic attacks showed rapid improvement, whereas improvement of anticipatory anxiety and phobic avoidance was more variable. Successful alprazolam therapy appeared to block lactate vulnerability. High pretreatment Hamilton Anxiety Scale scores were associated with poor treatment response. The data suggest that alprazolam is an effective treatment for panic disorder and agoraphobia with panic attacks, and acts by directly blocking panic attacks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
A key role for orexin in panic anxiety
Johnson, P. L., Truitt, W., Fitz, S. D., Minick, P. E., Dietrich, A., Sanghani, S., Träskman-Bendz, L., Goddard, A. W., Brundin, L., & Shekhar, A. (2010) · Nature Medicine · doi:10.1038/nm.2075 · Cited by 414
A neuroanatomical hypothesis for panic disorder
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.2.148 · Cited by 409
Neuroanatomical Correlates of a Lactate-Induced Anxiety Attack
Reiman, E. M. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810060013003 · Cited by 326
Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder
Pande, A. C., Pollack, M. H., Crockatt, J., Greiner, M., Chouinard, G., Lydiard, R. B., Taylor, C. B., Dager, S. R., & Shiovitz, T. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00011 · Cited by 279
Metadata
- Authors
- LIEBOWITZ, M. R., FYER, A. J., GORMAN, J. M., CAMPEAS, R., LEVIN, A., DAVIES, S. R., GOETZ, D., & KLEIN, D. F.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 1986-02
- Volume
- 6
- Issue
- 1
- Pages
- 13???20
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2007232098
- Cited by
- 92
- References
- 0
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alprazolam in the Treatment of Panic Disorders. https://app.cochat.ai/papers/10.1097/00004714-198602000-00004
- The paper
- LIEBOWITZ, M. R., FYER, A. J., GORMAN, J. M., CAMPEAS, R., LEVIN, A., DAVIES, S. R., GOETZ, D., & KLEIN, D. F. (1986). Alprazolam in the Treatment of Panic Disorders. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-198602000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.